SCHEMBL377335

SCHEMBL377335

ClCCSCCCCSCCCl

nearest known ligand 0.39

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.33
TSHR P16473 1/20 0.33
TDP1 Q9NUW8 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL472807 0.96 ALDH1A1 (0.31) ALDH1A1TSHRTDP1
SCHEMBL389363 0.92 ALDH1A1 (0.33) ALDH1A1TSHRTDP1
SCHEMBL4952021 0.89 ALDH1A1 (0.31) ALDH1A1TSHRTDP1
SCHEMBL43809 0.88
SCHEMBL9117801 0.88 ALDH1A1 (0.36) ALDH1A1TSHRTDP1
SCHEMBL539318 0.85
SCHEMBL2786153 0.85 TSHR (0.43) ALDH1A1TSHRTDP1
Water SCHEMBL23801211 0.84 ALDH1A1 (0.33) ALDH1A1TSHRTDP1
SCHEMBL11173104 0.84 ALDH1A1 (0.33) ALDH1A1TSHRTDP1
SCHEMBL384755 0.84 ALDH1A1 (0.33) ALDH1A1TSHRTDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 302 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11717532-B2 Methods and compositions for treating wounds utilizing chitosan compounds SYNEDGEN, INC. (US) 2023-08-08 US claimed
US-11071795-B2 Indicating devices based on etching of metals JP LABORATORIES INC. (US) 2021-07-27 US claimed
US-20180024011-A1 Indicating Devices Based on Etching of Metals JP LABORATORIES INC. 2018-01-25 US claimed
US-8557730-B2 Composition and process for making the composition MOLYCORP MINERALS, LLC (US) 2013-10-15 US claimed
US-8343437-B2 Monitoring system based on etching of metals JP LABORATORIES, INC. (US) 2013-01-01 US claimed
US-8252087-B2 Process and apparatus for treating a gas containing a contaminant MOLYCORP MINERALS, LLC (US) 2012-08-28 US claimed
JP-2011530085-A 2011-12-15 JP claimed
EP-2288879-A1 A MONITORING SYSTEM BASED ON ETCHING OF METALS Patel, G (US) 2011-03-02 EP claimed
US-20100168498-A1 APPARATUS AND PROCESS FOR TREATING AN AQUEOUS SOLUTION CONTAINING CHEMICAL CONTAMINANTS MOLYCORP MINERALS, LLC (US) 2010-07-01 US claimed
WO-2009149243-A1 A MONITORING SYSTEM BASED ON ETCHING OF METALS PATEL G (US) 2009-12-10 WO claimed
US-20090301382-A1 Monitoring System Based on Etching of Metals JP LABORATORIES, INC 2009-12-10 US claimed
US-20070114121-A1 Signal activated decontaminating coating CROSSLINK POLYMER RESEARCH (US) 2007-05-24 US claimed
EP-1166825-A1 Formulations for neutralization of chemical and biological toxants Sandia Corporation (US) 2002-01-02 EP claimed
US-20260123864-A1 TECHNIQUES AND DEVICES ASSOCIATED WITH BLOOD SAMPLING YOURBIO HEALTH, INC. (US) 2026-05-07 US disclosed
US-12594296-B2 Methods for treatment or prevention of damage resulting from radiation, trauma or shock SYNEDGEN, INC. (US) 2026-04-07 US disclosed
US-20260076595-A1 SYSTEMS AND INTERFACES FOR BLOOD SAMPLING YOURBIO HEALTH, INC. (US) 2026-03-19 US disclosed
US-20040067159-A1 Decontaminating systems containing reactive nanoparticles and biocides TIMILON CORPORATION 2004-04-08 US disclosed
US-6566574-B1 Especially chemical and biological weapons agents; both a cationic quaternary ammonium surfactant and a cationic hydrotrope as solubilizing compounds, and at least one at least one nucleophilic or oxidizing reactive compound SANDIA CORPORATION 2003-05-20 US disclosed
WO-2002034998-A2 CHEMICAL WARFARE PROOF TENT SHOT FABRIC STEDFAST INC. (CA) 2002-05-02 WO disclosed
EP-1166825-A1 Formulations for neutralization of chemical and biological toxants Sandia Corporation (US) 2002-01-02 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12594296-B2 Methods for treatment or prevention of damage resulting from radiation, trauma or shock SIRT1, SIRT3, CASP1 ALDH1A1 2216/4885TSHR 1766/4885TDP1 3308/4885
US-20260076595-A1 SYSTEMS AND INTERFACES FOR BLOOD SAMPLING MMP1, MMP8, CUTA ALDH1A1 4307/4885TSHR 2834/4885TDP1 1926/4885
US-20260123864-A1 TECHNIQUES AND DEVICES ASSOCIATED WITH BLOOD SAMPLING SLC2A9, SLC2A3, MMP8 ALDH1A1 4604/4885TSHR 3460/4885TDP1 4193/4885
US-11717532-B2 Methods and compositions for treating wounds utilizing chitosan compounds CHIA, MMP8, CHIT1 ALDH1A1 2248/4885TSHR 4714/4885TDP1 3796/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.